HIV/AIDS Topics AIDS 2012: Nick Rhoades -- Criminal Transmission of HIV [VIDEO]
- Details
- Category: HIV Prevention
- Published on Wednesday, 01 August 2012 00:00
- Written by Gregory Fowler
In 2008 Nick Rhoades was convicted of "Criminal Transmission of HIV" in Iowa, even though his viral load was undetectable, he used a condom, and his accuser did not contract HIV. He told his story at a press conference at the XIX International AIDS Conference (AIDS 2012) last week in Washington, DC.
AIDS 2012: Syringe Exchange Expansion in U.S. Would be Cost-saving
- Details
- Category: HIV Prevention
- Published on Tuesday, 31 July 2012 00:00
- Written by Kelly Safreed-Harmon
According to a mathematical analysis presented at the XIX International AIDS Conference (AIDS 2012) last week in Washington, DC, providing clean syringes to reduce HIV transmission among Americans who inject drugs is considerably less expensive than treating the new cases of HIV that would occur in the absence of this intervention.
Coverage of the XIX International AIDS Conference
- Details
- Category: HIV Treatment
- Published on Friday, 27 July 2012 00:00
- Written by Liz Highleyman
HIVandHepatitis.com coverage of the XIX International AIDS Conference (AIDS 2012), July 22-27 in Washington, DC.
Conference highlights include experimental antiretroviral drugs, treatment as prevention and PrEP, scaling up HIV treatment and prevention in resource-limited countries, human rights and concerns of heavily impacted populations, AIDS policy and advocacy, HIV/HBV and HIV/HCV coinfection, and the search for a cure for HIV.
HIVandHepatitis.com AIDS 2012 conference section
7/27/12
AIDS 2012: Does Hormonal Contraception Increase the Risk of HIV Infection?
- Details
- Category: HIV Prevention
- Published on Friday, 27 July 2012 00:00
- Written by Gus Cairns
The 19th International AIDS Conference (AIDS 2012) heard further contradictory evidence this week on whether hormonal contraceptives, especially injectable ones, raise the risk to women of acquiring HIV and, if they already have HIV, of developing AIDS.
NEXT-PrEP Trial Will Test CCR5 Blocker Maraviroc for HIV Prevention
- Details
- Category: HIV Prevention
- Published on Friday, 20 July 2012 00:00
- Written by Press Release
The National Institutes of Health (NIH) this week announced a new clinical trial to assess whether taking the CCR5 antagonist maraviroc (Selzentry) daily -- alone or with other antiretroviral drugs -- can help lower the risk of HIV infection.
Web Design and Development by